The first batch took twenty-one days.
Not because Shen Mingzhu was slow.
Because he was precise.
Every milligram measured twice. Every temperature checked three times. Every compound added in the exact sequence that ten thousand years of refinement had burned into his memory like scripture.
He had no cauldron. No heavenly fire. No spiritual herbs pulled from the peak of immortal mountains.
He had a rented commercial mixer, a temperature controller from an online supplier, and ingredients sourced from three different vendors because no single supplier carried everything at the quality he required.
It was, by any reasonable measure, the most humble pill refinement of his entire existence.
He treated it with the same reverence as his greatest work.
Twenty-one days after Derek wired three thousand dollars —
Three formulations sat in clean, unlabeled containers on the bathroom shelf.
ClearMind. The nootropic stack. Peak mental clarity. Focus sharp enough to cut.
AdaptaCore. The stress-response formula. For people whose bodies had forgotten what calm felt like.
ReVita. The partial vitality restoration formula. His most complex work. Cellular repair. Inflammation response. Immune function optimized at a level this world's science hadn't reached yet.
He looked at them for a long moment.
Then he called Derek.
"It's ready."
Derek distributed them to twenty gym clients.
Free samples. Two week trial. Honest feedback requested.
The feedback came back in one week.
Derek called sounding like a man who had seen something he couldn't explain.
"Ryan." His voice was strange. "I have people calling me crying."
Shen Mingzhu paused. "Adverse reactions?"
"No! Ryan — one of my clients has had chronic fatigue syndrome for six years. Six years. She said within ten days she feels like a completely different person." A breath. "Another guy with inflammatory arthritis said his pain dropped by half. I have a sixty year old woman saying her brain fog is gone for the first time since menopause."
Silence.
"What did you put in these?"
"Precisely calibrated compounds in correct ratios," Shen Mingzhu said. "All ingredients commercially available. All legal. The formulation is mine."
"Ryan." Derek's voice dropped. "My cousin wants to talk to you. Urgently. She's already contacted two colleagues. One of them is a researcher at Johns Hopkins."
"I'm not giving away the formulation."
"They don't want the formula." A pause. "They want to study the people."
He let Priya coordinate.
What he did not anticipate was the blogger.
One of Derek's gym clients. Lifestyle content. Four hundred thousand followers. She posted about ReVita with the unhinged energy of someone who had been handed back something they'd given up on entirely.
The post went moderately viral.
Then a journalist picked it up.
Then a larger publication.
The story was irresistible — a small batch, independently formulated supplement. No celebrity backing. No marketing budget. No hype machine.
Just results that shouldn't have been possible.
Shen Mingzhu's phone — previously used to order food and ignore debt collection messages — started ringing constantly.
He handled every interview the same way.
Precise. Calm. Zero overselling.
He said the formulations were built on established science applied with unusual precision. He declined to compare them to pharmaceutical products. He said results varied. He made no medical claims.
He was, by unanimous journalistic assessment, the least hype-y person they had ever spoken to about something generating enormous hype.
This made people trust it more.
Six weeks after the first batch —
Three thousand people on the waiting list.
Two acquisition offers from major supplement companies.
Both declined.
Derek sat across from him at the dinner table — he had somehow become a permanent fixture at dinner, appearing three times a week without invitation and never being asked to leave — and stared at him like he'd lost his mind.
"You turned down four million dollars," Derek said. "You turned it down like he was offering you expired coupons."
"The formula is worth substantially more than four million properly developed," Shen Mingzhu said, serving the hotpot he'd made from scratch. "I have no interest in selling it. I'm building the company."
"With what capital?"
"I'm working on it."
Elena looked up from her phone across the table.
She had started joining dinner somewhere around week four. Gradually. The way you approach something uncertain but increasingly hard to avoid.
"How much do you need?" she asked.
He looked at her. "I'm not asking you for money. You have enough to manage."
"The criminal case against Wren is moving." Her voice was business-flat. Controlled. "Two investors came back this week. The pharmaceutical distribution hold lifts next week." She set her phone down. "I have liquidity again. And I have a distribution network sitting there doing nothing."
Derek pointed at her with his chopsticks. "She's right."
"If your formulations are what people are saying—" she started.
"They are," Derek said.
"—then distribution is your bottleneck." She held his gaze. Steady. Direct. "I'm proposing a business arrangement. Not charity."
He looked at her for a moment.
Business arrangement.
Right.
"Your terms?" he asked.
She named them.
Sharp. Fair. Structured to protect both parties. Not a single clause that favored her unfairly. Not a single loophole left open.
He had negotiated with immortal sect leaders, heavenly tribunals, and demon lords who breathed fire when annoyed.
Elena Vasquez negotiated better than all of them.
"I'll add one condition," he said.
She raised an eyebrow.
"You eat dinner. Every night. Not at your desk."
A silence so complete Derek stopped chewing.
"That's not—" she started.
"Non-negotiable," he said pleasantly.
The silence stretched.
Elena looked at him.
He looked back.
"Fine," she said.
Derek exhaled like he'd been holding his breath for a week.
The partnership announcement hit the business press two weeks later.
Calloway Formulations enters exclusive distribution agreement with Vasquez Holdings pharmaceutical arm.
Small news. Niche industry coverage.
But the people paying attention — the investors who had fled, the analysts who had written Elena off, the competitors who had been circling her collapsed empire like patient vultures —
They noticed.
And they started asking questions.
The comeback had begun.
Nobody realized yet just how far it would go.